Viking Therapeutics, Inc. (VKTX)
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Viking Therapeutics, Inc.
NASDAQ:VKTXHealthcare · Biotechnology
+1.56%$27.28
AH$26.88-1.47%vs close
Mkt Cap$3.48B
Float112.06M
O/S127.52M
Vol
$ Vol
RVOL
Inst Own59.2%
SI22.8%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$359.64M
Total Assets$715.73M
Free Cash Flow-$278.69M
Debt & Equity
Debt 0%
Equity 100%
Total Debt$137K
Total Equity$639.06M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in VKTX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$715.73M
Liabilities$76.67M
Accounts Receivable$0
Accounts Payable$53.25M
Inventory$0
PP&E (Net)$85K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $431K | $0 | $0 | $0 | $0 | $0 | $260K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | -$431K | $0 | $0 | $0 | $0 | $0 | -$260K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $344.95M | $101.64M | $63.81M | $54.23M | $44.98M | $31.93M | $23.56M | $19.04M | $13.74M | $9M | $6.97M | $22.22M | $12K | $275 |
| Selling, General, and Administrative | $48.39M | $49.28M | $37.02M | $16.12M | $10.7M | $10.73M | $8.87M | $7.12M | $5.33M | $4.85M | $5.03M | $1.24M | $89K | $163 |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $393.34M | $150.92M | $100.83M | $70.36M | $55.68M | $42.66M | $32.43M | $26.16M | $19.07M | $13.85M | $12M | $23.47M | $101K | $439 |
| Operating Income (EBIT) | -$393.34M | -$150.92M | -$100.83M | -$70.36M | -$55.68M | -$42.66M | -$32.69M | -$26.16M | -$19.07M | -$13.85M | -$12M | -$23.47M | -$101K | -$439 |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $94K | $88K | $59K | $18K | $106K | $146K | $562K | $1.95M | $2.03M | $1.02M | $629K | $25K | $0 |
| Interest Income | $33.7M | $40.94M | $15.02M | $1.59M | $703K | $3.23M | $7.05M | $3.27M | $98K | $84K | $36K | $0 | $0 | $6 |
| Other Income (Expense) | $33.7M | $40.96M | $14.93M | $1.49M | $692K | $3.17M | $6.91M | $4.1M | -$1.51M | -$885K | -$11.41M | $1.58M | -$45K | -$111K |
| Income Before Tax (EBT) | -$359.64M | -$109.96M | -$85.89M | -$68.87M | -$54.99M | -$39.49M | -$25.78M | -$22.06M | -$20.58M | -$14.73M | -$23.4M | -$21.88M | -$146K | -$444 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$6 |
| Net Income | -$359.64M | -$109.96M | -$85.89M | -$68.87M | -$54.99M | -$39.49M | -$25.78M | -$22.06M | -$20.58M | -$14.73M | -$23.4M | -$21.88M | -$146K | -$444 |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||||||||
| EPS | -3.19 | -1.01 | -0.91 | -0.88 | -0.70 | -0.50 | -0.36 | -0.38 | -0.79 | -0.90 | -3.68 | -5.08 | -0.03 | -0.30 |
| Diluted EPS | -3.19 | -1.01 | -0.91 | -0.88 | -0.70 | -0.50 | -0.36 | -0.38 | -0.79 | -0.90 | -3.68 | -5.08 | -0.03 | -0.30 |
| Weighted Average OS | 112.67M | 109.04M | 94.35M | 76.83M | 77.20M | 72.60M | 71.96M | 57.58M | 25.98M | 16.28M | 6.36M | 4.31M | 4.31M | 1,482 |
| EBITDA | -$359.15M | -$109.52M | -$85.52M | -$68.52M | -$54.68M | -$39.11M | -$25.37M | $4.66M | $443K | -$10.77M | -$21.36M | -$22.91M | -$122K | -$109K |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $165.81M | $26.68M | $55.52M | $36.63M | $26.37M | $29.12M | $8.38M | $24.78M | $8.99M | $3.08M | $769K | $756K | $180K | $0 |
| Short-Term Investments | $539.93M | $875.94M | $306.56M | $118.85M | $175.73M | $219.27M | $267.26M | $276.74M | $11.59M | $10.08M | $13.34M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $705.74M | $902.61M | $362.08M | $155.49M | $202.1M | $248.39M | $275.64M | $301.52M | $20.58M | $13.15M | $14.1M | $756K | $180K | $0 |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1.81M | $1.13M | $2.52M | $8.14M | $7.81M | $7.28M | $7.46M | $0 | $389K | $824K | $0 | $0 | $0 | $0 |
| Total Current Assets | $715.6M | $907.22M | $367.23M | $167.04M | $210.53M | $256.1M | $283.5M | $302.13M | $21.85M | $13.97M | $15.2M | $774K | $180K | $0 |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $85K | $1M | $1.13M | $1.42M | $25K | $321K | $598K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $46K | $102K | $139K | $71K | $109K | $78K | $157K | $179K | $270K | $561K | $237K | $2.27M | $775 | $0 |
| Total Long-Term Assets | $131K | $1.1M | $1.26M | $1.49M | $134K | $399K | $755K | $179K | $270K | $561K | $237K | $2.27M | $775 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $715.73M | $908.32M | $368.49M | $168.53M | $210.66M | $256.5M | $284.26M | $302.31M | $22.12M | $14.54M | $15.44M | $3.04M | $180K | $0 |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $53.25M | $9.81M | $7.51M | $8.53M | $1.44M | $3.99M | $2.43M | $959K | $1.53M | $1.2M | $592K | $1.83M | $73K | $54K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.45M | $3.27M | $0 | $304K | $47K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.28M | $1.27M | $0 | $20.32M | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.4M | $731K | $0 | $59K | $0 | $0 |
| Total Current Liabilities | $76.67M | $27.41M | $19.14M | $21.95M | $8.78M | $12.13M | $6.78M | $4.55M | $8.66M | $6.48M | $1.98M | $22.52M | $127K | $54K |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.15M | $1.26M | $232K | $43K |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12K | $0 | $16K | $2.59M | $1.39M | $72K | $8K |
| Total Long-Term Liabilities | $0 | $630K | $936K | $1.26M | $0 | $29K | $360K | $12K | $4.98M | $16K | $4.74M | $2.65M | $304K | $51K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$4.98M | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $76.67M | $28.04M | $20.07M | $23.21M | $8.78M | $12.16M | $7.14M | $4.56M | $8.66M | $6.49M | $6.71M | $25.17M | $431K | $105K |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $1K | $1K | $1K | $1K | $1K | $1K | $1K | $1K | $358 | $208 | $97 | $60 | $52 | $50 |
| Retained Earnings | -$847.55M | -$487.91M | -$377.94M | -$292.05M | -$223.18M | -$168.19M | -$128.7M | -$102.92M | -$80.85M | -$60.28M | -$45.55M | -$22.14M | -$257K | -$111K |
| Comprehensive Income & Other | $378K | -$788K | -$389K | -$1.1M | -$549K | -$54K | $12K | -$423K | -$20K | -$7K | -$7K | $0 | -$4K | $0 |
| Other Stockholders' Equity | $1.49B | $1.37B | $726.36M | $437.37M | $425.06M | $412.54M | $405.81M | $400.67M | $94.32M | $68.32M | $54.27M | $13K | $7K | $6K |
| Total Equity | $639.06M | $880.28M | $348.42M | $145.32M | $201.88M | $244.34M | $277.12M | $297.75M | $13.46M | $8.04M | $8.72M | -$22.13M | -$251K | -$105K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $715.73M | $908.32M | $368.49M | $168.53M | $210.66M | $256.5M | $284.26M | $302.31M | $22.12M | $14.54M | $15.44M | $3.04M | $180K | $0 |
| Supplementary Data | ||||||||||||||
| Total Debt | $137K | $1.12M | $1.26M | $1.56M | $29K | $359K | $662K | $0 | $3.45M | $3.27M | $2.15M | $1.57M | $279K | $43K |
| Net Debt | -$165.67M | -$25.56M | -$54.26M | -$35.07M | -$26.34M | -$28.76M | -$7.71M | -$24.78M | -$5.54M | $194K | $1.38M | $813K | $99K | $43K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$359.64M | -$109.96M | -$85.89M | -$68.87M | -$54.99M | -$39.49M | -$25.78M | -$22.06M | -$20.58M | -$14.73M | -$23.4M | -$21.88M | -$146K | -$444 |
| Depreciation & Amortization | $431K | $346K | $292K | $291K | $296K | $277K | $260K | $26.16M | $19.07M | $1.93M | $1.03M | $558K | $0 | $439 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$392K | -$1.28M | -$1.79M | -$894K | $0 | $0 | $0 |
| Stock-Based Compensation | $40.82M | $29.71M | $16.75M | $8.67M | $6.1M | $5.82M | $3.74M | $2.61M | $1.45M | $1.79M | $2.6M | $6K | $4 | $22 |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $5.08M | $1.2M | $321K | $614K | $1.18M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $43.44M | $2.3M | -$1.02M | $7.08M | -$2.54M | $1.55M | $1.47M | -$508K | $264K | $677K | $219K | $190K | $20K | $0 |
| Other Working Capital | $464K | $5.86M | $4.25M | $2.49M | -$1.56M | $6.16M | -$5.25M | $1.33M | $1.51M | $173K | $401K | $21.75M | $5K | $0 |
| Total Working Capital Change | $48.98M | $9.36M | $3.55M | $10.19M | -$2.93M | $7.72M | -$3.78M | $823K | $1.77M | $850K | $620K | $21.94M | $25K | $0 |
| Other Non-Cash Items | -$9.27M | -$17.25M | -$8.07M | $1.32M | $3.94M | $3.91M | $807K | -$25.89M | -$15.19M | $878K | $11.32M | -$2.21M | $43K | -$217 |
| Net Cash from Operating | -$278.69M | -$87.79M | -$73.38M | -$48.4M | -$47.59M | -$21.78M | -$24.75M | -$18.75M | -$14.76M | -$11.07M | -$8.73M | -$1.59M | -$78K | -$200 |
| Investing Activities | ||||||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$418.04M | -$1.11B | -$478.3M | -$121.43M | -$168.01M | -$280.64M | -$362.41M | -$348.2M | -$22.53M | -$16.92M | -$16.03M | $0 | $0 | $0 |
| Sales of Investments | $759.42M | $560M | $299.22M | $176.18M | $205.97M | $322.2M | $369.87M | $82.47M | $20.8M | $19.95M | $2.56M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $55K | $0 | $0 | $0 | -$266K | -$2K | $3K | -$13K | $0 | $0 | $0 |
| Net Cash from Investing | $341.39M | -$553.37M | -$179.09M | $54.75M | $37.96M | $41.57M | $7.46M | -$265.73M | -$1.73M | $3.03M | -$13.47M | $0 | $0 | $0 |
| Financing Activities | ||||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | $3.83M | $77K | $95K | - | -$2.5M | -$260K | - |
| Common Stock Issuance | $2.49M | $597.09M | $269.76M | $0 | $7.59M | $1.25M | $1.04M | $296.61M | $22.35M | $11.55M | $25.39M | $0 | $7 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | -$6.79M | $0 | $0 | $0 | $0 | $0 | -$229 | -$38 | -$2 | -$3K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $73.95M | $15.37M | $1.62M | $12.49M | -$707K | -$296K | -$151K | $7.5M | $125K | -$1.1M | -$3.18M | -$332K | $0 | $200 |
| Net Cash from Financing | $76.44M | $612.46M | $271.38M | $4.16M | $6.88M | $950K | $887K | $300.27M | $22.4M | $10.35M | $22.21M | $2.17M | $258K | $200 |
| Forex Effect | -$8K | -$148K | -$30K | -$258K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $139.13M | -$28.84M | $18.88M | $10.26M | -$2.75M | $20.74M | -$16.4M | $15.79M | $5.91M | $2.31M | $13K | $576K | $180K | $0 |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$278.69M | -$87.79M | -$73.38M | -$48.4M | -$47.59M | -$21.78M | -$24.75M | -$18.75M | -$14.76M | -$11.07M | -$8.73M | -$1.59M | -$78K | -$200 |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$278.69M | -$87.79M | -$73.38M | -$48.4M | -$47.59M | -$21.78M | -$24.75M | -$18.75M | -$14.76M | -$11.07M | -$8.73M | -$1.59M | -$78K | -$200 |
| Cash at Beginning | $26.68M | $55.52M | $36.63M | $26.37M | $29.12M | $8.38M | $24.78M | $8.99M | $3.08M | $769K | $756K | $180K | $0 | $0 |
| Cash at End | $165.81M | $26.68M | $55.52M | $36.63M | $26.37M | $29.12M | $8.38M | $24.78M | $8.99M | $3.08M | $769K | $756K | $180K | $0 |